AstraZeneca

News

UCB preps filings for another challenger to AZ's Soliris

Belgian drugmaker UCB says it will be able to file not one but two new drug therapies for autoimmune disease generalised myasthenia gravis (gMG) this year, after its C5 inhibitor zilucoplan

News

NICE expands cover for AZ's high potassium drug Lokelma

NICE has recommended extending funding via the NHS for AstraZeneca's elevated potassium therapy Lokelma in new guidance, making it easier to receive the drug outside hospital settings.

Patients

3D Illustration Concept of Human Urinary System Kidneys Anatomy

Chronic kidney disease: treating a silent killer

In November, NICE backed NHS use of AstraZeneca’s diabetes and heart failure drug Forxiga for the treatment of chronic kidney disease.

News

Scotland backs AstraZeneca drug as first-line treatment for ...

Scotland has approved AstraZeneca’s Tagrisso (osimertinib) as a monotherapy for the for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung ca

News

AZ, Scorpion strike deal on elusive transcription factor tar...

AstraZeneca has expanded its efforts to develop new therapies targeting transcription factors – proteins that regulate processes in the cell that have become a hot topic for drug discovery

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Third dose of AZ's COVID jab boosts Omicron antibodies

Preliminary data from an ongoing trial of AstraZeneca's COVID-19 vaccine Vaxzevria has shown that a booster dose stimulates an increase in antibodies against Omicron, as well as other varia

UCB preps filings for another challenger to AZ's Soliris

NICE expands cover for AZ's high potassium drug Lokelma

Chronic kidney disease: treating a silent killer

Scotland backs AstraZeneca drug as first-line treatment for ...

AZ, Scorpion strike deal on elusive transcription factor tar...

Third dose of AZ's COVID jab boosts Omicron antibodies

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

AstraZeneca

Editor's Picks